Clinical Trials in Zhejiang, China
12 recruiting
Showing 1–20 of 21 trials
Recruiting
Phase 3
A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)
Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer
Hoffmann-La Roche1,050 enrolled351 locationsNCT06065748
Recruiting
A Study on the Efficacy and Safety of Switching Between Two Targeted Strategies, HP+Chemotherapy and HPy+Chemotherapy, After Treatment Progression in HER-2 Positive Advanced or Metastatic Breast Cancer
Breast Cancer
Zhejiang Cancer Hospital600 enrolled1 locationNCT07455188
Recruiting
Phase 3
A Study to Assess the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of Tazemetostat in Combination With Lenalidomide Plus Rituximab Versus Placebo in Combination With Lenalidomide Plus Rituximab in Adult Patients at Least 18 Years of Age With Relapsed/Refractory Follicular Lymphoma.
Refractory Follicular LymphomaFollicular LymphomaRelapsed/Refractory Follicular Lymphoma
Epizyme, Inc.612 enrolled229 locationsNCT04224493
Recruiting
Phase 3
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
Multiple Myeloma
European Myeloma Network B.V.1,594 enrolled210 locationsNCT05243797
Recruiting
Phase 3
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
Extensive-stage Small-cell Lung Cancer
BioNTech SE621 enrolled138 locationsNCT06712355
Recruiting
Phase 3
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
Metastatic Breast Cancer
Sermonix Pharmaceuticals Inc.500 enrolled222 locationsNCT05696626
Recruiting
Phase 1
FORAGER-1: A Study of LOXO-435 (LY3866288) in Participants With Cancer With a Change in a Gene Called FGFR3
Urinary Bladder NeoplasmsNeoplasm MetastasisUreteral Neoplasms
Eli Lilly and Company535 enrolled84 locationsNCT05614739
Recruiting
Not Applicable
Effectiveness of Artificial IntelliGence-Driven Single-LEad Long-TerM Electrocardiograms MonItoring in Detecting New-Diagnosed Atrial FIbrillation
Atrial Fibrillation (AF)
Beijing Anzhen Hospital15,360 enrolled1 locationNCT06842147
Recruiting
Phase 2
A Phase II Clinical Study Evaluating Entinostat With or Without Anlotinib + Fulvestrant for the Treatment of Hormone Receptor (HR) -Positive, Human Epidermal Growth Factor Receptor-2 (HER-2) -Negative Advanced Breast Cancer That Relapsed or Progressed After Endocrine Therapy
Breast Cancer
Zhejiang Cancer Hospital118 enrolled1 locationNCT07330544
Recruiting
Phase 3
Feasibility of Enhanced Recovery After Surgery Without Prophylactic Abdominal Drainage Tubes After Laparoscopic Distal Gastrectomy For Gastric Cancer
Gastric AdenocarcinomaComplicationsLaparoscopic Gastrectomy
Zuoyi Jiao454 enrolled6 locationsNCT07029269
Recruiting
Phase 1
JMT106 Injection in the Treatment of Advanced Solid Tumors
Hepatocellular CarcinomaAdvanced Solid TumorLung Squamous Cell Carcinoma
Shanghai JMT-Bio Inc.200 enrolled1 locationNCT07275073
Recruiting
Phase 2
Efficacy and Safety of Distamab Vedotin Combined With Carboplatin for Advanced Ovarian Cancer in the First Line Treatment
Ovarian CancerHER2
Zhejiang Cancer Hospital20 enrolled1 locationNCT07285941
Recruiting
Not Applicable
A Multi-center RCT to Evaluate Subsegmental BTVA Treatment for Severe Emphysema
Severe Emphysema
Shanghai Chest Hospital100 enrolled9 locationsNCT06152107
Recruiting
The Efficacy and Safety of Third-generation TKIs Combined With Azacitidine and Bcl-2 Inhibitor in Patients With CML-MBP
Chronic Myeloid Leukemia
Peking University People's Hospital30 enrolled15 locationsNCT06390306
Recruiting
Lecanemab for Early Onset Familial Alzheimer's Disease
Alzheimer Disease
RenJi Hospital114 enrolled15 locationsNCT06883019
Recruiting
Phase 1
A Study of JMT203 in Patients With Cancer Cachexia
Colorectal, CancerPancreatic CancerNon-small Cell Lung Cancer+1 more
Shanghai JMT-Bio Inc.130 enrolled1 locationNCT06868849
Recruiting
Phase 3
89Zr-TLX250 for PET/CT Imaging of ccRCC - ZIRCON-CP Study
Clear Cell Renal Cell Carcinoma
Telix Pharmaceuticals (Innovations) Pty Limited82 enrolled8 locationsNCT06750419
Recruiting
Phase 1Phase 2
Fuzuloparib Arsenic Trioxide Platinum Resistance Relapsed Ovarian Cancer
Efficacy and Safety
Xing Xie50 enrolled1 locationNCT04518501
Recruiting
Phase 1Phase 2
Study of ZG005 in Combination With Paclitaxel＋Platinum-based ± Bevacizumab in Patients With Advanced Cervical Carcinoma
Cervical Carcinoma
Suzhou Zelgen Biopharmaceuticals Co.,Ltd48 enrolled1 locationNCT06241235
Recruiting
Phase 3
Effect of Electroacupuncture Combined With Paclitaxel Clinical Efficacy of Patients With Recurrence of High-grade Glioma
Glioma
The Third Affiliated hospital of Zhejiang Chinese Medical University58 enrolled1 locationNCT06330337